Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics

AIMS: Application of advanced molecular pathology in rare tumours is hindered by low sample numbers, access to specialised expertise/technologies and tissue/assay QC and rapid reporting requirements. We assessed the feasibility of co‐ordinated real‐time centralised pathology review (CPR), encompassi...

Descripción completa

Detalles Bibliográficos
Autores principales: Crosier, Stephen, Hicks, Debbie, Schwalbe, Edward C., Williamson, Daniel, Leigh Nicholson, Sarah, Smith, Amanda, Lindsey, Janet C., Michalski, Antony, Pizer, Barry, Bailey, Simon, Bown, Nick, Cuthbert, Gavin, Wharton, Stephen B., Jacques, Thomas S., Joshi, Abhijit, Clifford, Steven C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600954/
https://www.ncbi.nlm.nih.gov/pubmed/33826763
http://dx.doi.org/10.1111/nan.12716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600954/
https://www.ncbi.nlm.nih.gov/pubmed/33826763
http://dx.doi.org/10.1111/nan.12716

Ejemplares similares